| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 448.021 | 91 |
| GSM780708 | Untreated after 4 days (C2_1) | 507.568 | 92 |
| GSM780709 | Untreated after 4 days (C3_1) | 601.531 | 93 |
| GSM780719 | Untreated after 4 days (C1_2) | 476.925 | 91 |
| GSM780720 | Untreated after 4 days (C2_2) | 543.552 | 92 |
| GSM780721 | Untreated after 4 days (C3_2) | 615.351 | 93 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 557.722 | 92 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 487.91 | 91 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 506.5 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 580.19 | 93 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 513.729 | 92 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 515.009 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 514.435 | 92 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 536.568 | 92 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 484.379 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 481.501 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 547.709 | 92 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 526.679 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 609.061 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 580.578 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 430.788 | 90 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 602.068 | 93 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 551.206 | 92 |